Food and Drug Administration perspective on negative symptoms in schizophrenia as a target for a drug treatment claim (Q37075859)

From Wikidata
Jump to navigation Jump to search
scientific article published on 03 August 2005
edit
Language Label Description Also known as
English
Food and Drug Administration perspective on negative symptoms in schizophrenia as a target for a drug treatment claim
scientific article published on 03 August 2005

    Statements

    Food and Drug Administration perspective on negative symptoms in schizophrenia as a target for a drug treatment claim (English)
    Thomas Laughren
    Robert Levin
    3 August 2005
    220-222

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit